| Pharmaceutical active ingredients: |
| Tamoxifen |
| Available forms, composition and doses of Retaxim: |
| N / A |
| Retaxim medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapyHormonal chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L02BA01 - Tamoxifen |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Retalon | Dienestrol | Unidentified Pharmaceutical Company |
| Retamid | Sulfamethoxypyridazine | Unidentified Pharmaceutical Company |
| Retardo | Phenformin | Unidentified Pharmaceutical Company |
| Retardon | Sulfaperin | Unidentified Pharmaceutical Company |
| Retasulfin | Sulfamethoxypyridazine | Unidentified Pharmaceutical Company |
| Retcol | Chlordiazepoxide | Unidentified Pharmaceutical Company |
| Retinal | Vitamin A | Unidentified Pharmaceutical Company |
| Retozide | Isoniazid | Unidentified Pharmaceutical Company |
| Retrangor | Benziodarone | Unidentified Pharmaceutical Company |
| Retrocortine | Prednisone | Unidentified Pharmaceutical Company |